Axogen, Inc. — Director's Dealing 2022

Feb 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2022-02-15

Reporting Person: Zaderej Karen L. (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-15	Common Stock	A	13978	—	Acquired	940383	Direct

Footnotes

F1: This reflects the number of shares that became vested as of February 15, 2022 upon the attainment of certain performance criteria.

F2: Includes 728 shares acquired under the Axogen stock purchase plan on December 31, 2021.